BAQSIMI

BAQSIMI is indicated for the treatment of severe hypoglycemia in individuals with diabetes who are 4 years of age and older.

Baqsimi is accepted by the majority of Medicare and insurance plans. Let’s compare it to other insulin antagonists.

To be eligible, you must be 18 years of age or older and a resident of the United States or Puerto Rico. Please note that my prescription claims for BAQSIMI cannot be reimbursed by any government-funded program, such as Medicaid, Medicare, Medicare Part D, and others.

No, purchasing the injection form of glucagon without a prescription is not possible. It is necessary to obtain a prescription from your doctor in order to acquire glucagon. If you have type 1 or type 2 diabetes, it is recommended to discuss the possibility of obtaining a prescription for glucagon with your doctor.

BAQSIMI has the potential to cause serious side effects, such as high blood pressure, particularly in individuals with adrenal gland tumors. Additionally, it may also lead to low blood sugar levels.

There are currently no known interactions between alcohol and Baqsimi. However, it is important to note that consuming alcohol can make it more difficult to control your blood sugar levels. Additionally, it may hinder your ability to recognize symptoms of low blood sugar. If you do consume alcohol, it is recommended that you consult with your doctor before taking Baqsimi.

The questionnaire-solicited adverse reactions for BAQSIMI included the following percentages: watery eyes (47.2%), nasal congestion (41.7%), nasal itching (27.8%), runny nose (25.0%), sneezing (19.4%), itchy eyes (16.7%), redness of eyes (13.9%), itching of throat (2.8%), and itching of ears (2.8%).

Glucagon, a hormone found naturally in the body, functions by instructing the liver to increase blood sugar levels. The glucagon present in BAQSIMI is composed of the same active ingredient that has been in use for many years. Through a clinical study, BAQSIMI demonstrated comparable effectiveness to injectable glucagon in raising blood sugar levels in adults.

The discontinuation of GLUCAGON (Glucagon for injection, rDNA origin) and our GLUCAGON Emergency Kit globally is expected to be completed by the end of June 2023 in Canada. This decision has been made in response to a decline in demand and to optimize our manufacturing operations.

Before you require assistance, ensure that your caregiver is aware of the location of your BAQSIMI and knows how to properly administer it. Your doctor will provide instructions on the correct usage and timing of BAQSIMI. It is important to note that BAQSIMI contains a single dose of medication and cannot be reused.

Baqsimi is accepted by the majority of Medicare and insurance plans. Let’s compare it to other insulin antagonists.

The Baqsimi nasal device is a single-use device that contains only one dose. It cannot be reused. In the case of a severe hypoglycemia episode, it may be necessary to administer more than one dose of Baqsimi.

In Study 2, treatment success was achieved by 98.8 percent of patients treated with BAQSIMI and 100 percent of patients treated with glucagon for injection, according to the study’s definition.

Discovered in Canada, the formulation is revolutionizing the lives of individuals with diabetes globally. Baqsimi TM (glucagon nasal powder 3 mg) has been granted ethical status by Health Canada, allowing it to be obtained at pharmacies with or without a prescription.

Baqsimi (glucagon), GlucaGen (glucagon), Gvoke (glucagon) are available in nasal powder and injectable powder for injection dosage forms. Other brands of glucagon include GlucaGen and Gvoke.

With a NowPatient Rx Advantage Card, the prices for Baqsimi (glucagon) can be as low as $284.07.

The questionnaire-solicited adverse reactions for BAQSIMI included the following percentages: watery eyes (47.2%), nasal congestion (41.7%), nasal itching (27.8%), runny nose (25.0%), sneezing (19.4%), itchy eyes (16.7%), redness of eyes (13.9%), itching of throat (2.8%), and itching of ears (2.8%).

However, individuals with type 2 diabetes who are taking insulin can also develop hypoglycemia. Therefore, it is crucial for all individuals with diabetes to monitor their blood sugar levels. In the case of severe hypoglycemia, immediate administration of glucagon is necessary. If an individual has lost consciousness, someone can administer a glucagon shot to raise their blood sugar levels.

Instructions:
1. Place the device between your fingers and thumb, ensuring a firm grip.
2. Do not push the plunger yet.
3. Gently insert the tip of the device into one nostril until your finger(s) touch the outside of your nose.
4. Once the tip is in position, firmly push the plunger all the way in.
5. The dose is complete when the green line on the device disappears.

Glucagon, a hormone produced by the pancreas, functions to increase blood sugar levels. In medical practice, a synthetic form of glucagon is utilized to address severe hypoglycemia in individuals with diabetes.

In study 2, the average lowest blood glucose level was 44.2 mg/dL for BAQSIMI and 47.2 mg/dL for glucagon injection. Treatment success was determined as achieving a plasma glucose level of 70 mg/dL or higher, or an increase of at least 20 mg/dL from the lowest glucose level within 30 minutes of receiving the glucagon.

Nausea, vomiting, and headache are the most frequently reported adverse reactions. Nasal administration may also cause nasal congestion, itching, and watery eyes.

Excessively elevated blood sugar levels, such as those exceeding 1000 mg/dL, can result in the development of diabetic ketoacidosis, a condition that poses a risk of unconsciousness and is potentially fatal. The recommended approach to address this issue involves administering intravenous fluids and insulin.

The majority of adverse reactions associated with BAQSIMI were temporary and typically resolved within a span of 3 hours. These reactions primarily involved irritation of the upper respiratory tract, including symptoms such as runny nose, nasal discomfort, nasal congestion, coughing, and nosebleeds.

When blood sugar levels are excessively high, the surplus sugar is excreted through urine. This initiates a mechanism that causes a significant loss of fluid from the body. If left untreated, this can result in severe dehydration and a potentially fatal diabetic coma. Additionally, hypoglycemia may occur.

In the event of a medical emergency, please call for immediate assistance. If the person is unconscious, carefully place them on their side. Dispose of the used device and tube. Encourage the person to eat as soon as they are able. If there is no response after 15 minutes, and if available, another dose may be administered.

Glucagon and insulin work together to regulate blood sugar levels and maintain them within a specific range. Glucagon is responsible for preventing blood sugar levels from dropping too low, while insulin prevents them from rising too high.

In a research involving individuals with good health, the administration of 1 mg Glucagon for Injection under the skin led to an average peak blood glucose level of 79.3 mg/dL, with a median time of 50 minutes after the injection.

Baqsimi begins to take effect within 7 to 8 minutes after it is administered, and its highest levels are reached 30 minutes after administration. In clinical trials, Baqsimi successfully treated severe hypoglycemia in 100% of individuals within 30 minutes.

BAQSIMI is effective even if you have a cold or are using cold medicine. In case of administering BAQSIMI, the caregiver should immediately seek emergency medical assistance. If there is no response within 15 minutes, another dose may be administered, if it is accessible. It is important to inform your doctor every time you use BAQSIMI.

In the event of a medical emergency, please call for immediate assistance. If the person is unconscious, carefully place them on their side. Dispose of the used device and tube. Encourage the person to eat as soon as they are able. If there is no response after 15 minutes, and if available, another dose may be administered.

To identify a diabetic seizure, watch for signs like a blank stare, confusion, weakness in the muscles, loss of consciousness, or involuntary body movements.